Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: systematic review and network meta-analysis

Background: Janus kinase (JAK) inhibitors have emerged as a progressively utilized therapeutic approach for the management of rheumatoid arthritis (RA). However, the complete determination of their cardiovascular safety remains inconclusive. Hence, the primary objective of this network meta-analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Qige, Wang, Hui, Zhao, Jianglin, Luo, Zhongping, Wang, Chufeng, Zhu, Chunmei, Su, Na, Zhang, Shengzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442954/
https://www.ncbi.nlm.nih.gov/pubmed/37614310
http://dx.doi.org/10.3389/fphar.2023.1237234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442954/
https://www.ncbi.nlm.nih.gov/pubmed/37614310
http://dx.doi.org/10.3389/fphar.2023.1237234

Ejemplares similares